The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for haematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.

Haematologists and affiliated professionals attending the EHA Congress will be able to:

• Enhance their knowledge of evidence-based approaches on diagnosis and treatment for haematologic diseases.
• Access the latest results on clinical and translational research in hematologic disorders.
• Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in haematology and its subspecialties.
• Communicate, collaborate and network with representatives of a large international audience – medical professionals, national haematology societies, patient groups, medical industry and the media.